The chemokine RANTES (CCL5) binds selectively to glycosaminoglycans (GAGs) 
Introduction
Chemokines selectively recruit and activate leukocyte populations, both during routine immunosurveillance and also during inflammation. The migration of cells is believed to require immobilization of the chemokines on proteoglycans in the extracellular matrix, and on the endothelial cell (2 ; 3). The glycosaminoglycan (GAG) moiety of the proteoglycan shows a wide range of structures, with heparin, heparan sulfate, chondroitin sulfate and dermatan sulfate being important members of the family. Changes in the type of intensity of proteoglycan expression are known to happen in a wide variety of inflammatory diseases. It has been suggested that these changes in glycosaminoglycan expression play a role in the localization of the inflammatory response, by localizing inflammatory cytokines and chemokines. (4) (5) (6) (7) Chemokines are a large family of small proteins with a remarkably highly conserved three dimensional monomeric structure (8) . This conserved structure is mediated by the formation of two disulfide bridges imposed by the conserved 4 cysteine motif rather than identity at the level of primary sequence which can be as low as 20%. The majority of chemokines (MIP-1α and 1β being the exceptions) are highly basic proteins with an isoelectric point around pH 9.0. All chemokines are able to bind heparin, although with varying affinities. We have previously shown that selectivity exists for the chemokine/GAG interaction for 4 chemokines investigated, IL-8, RANTES, MIP-1α and MCP-1 (9) . RANTES was shown to have the greatest range of selectivity with an affinity three orders of magnitude higher for heparin than for chondroitin sulfate. Despite its acidic isoelectric point, MIP-1α is still able to bind to GAGs, showing that the interaction is not simply a global electrostatic attraction of basic chemokines with acidic glycosaminoglycans. The complexation of chemokines with glycosaminoglycans prevents the binding of the chemokines to their receptors in most cases (9) . However, the GAG/chemokine interaction has also been reported to potentiate the activity of chemokines in some cases (10) .11
The XBBXBX and XBBBXXBX motifs, where B represents a basic residue, have been shown to be a common heparin binding motif for several proteins (12 ; 13). Inspection of the RANTES sequence showed that it had two clusters of basic residues: a BBXB cluster on the 40's loop ( 44 RKNR 47 ), and another cluster of basic residues towards the C terminal on the 50's loop (  55 KKWVR   59 ). The carboxy terminal region has been shown to be implicated in GAG binding for chemokines such as PF4 (14) , and MCP-1 (16 ), but bot necessarily through BBXB motifs. We have mutated the charged amino acids in these sequences, as point mutations as well as triple mutations, to alanine residues. These studies did not identify a major role for any single amino acid, but our findings demonstrate that the triple mutation of the 40's cluster abrogates 80% of the heparin binding capacity (sense) 5'-GCC AAC CCA GAG GCG GCA TGG GTT GCG GAG TAC ATC-3' and K55AK56AR59A ( 55 AAWVA 59 ) (anti-sense)5'-ACA CAC TTG GCG GTT CTT TCG GGT RANTES was produced as previously described (19) . The purity and authenticity of 15 N RANTES and the mutants was verified by reverse-phase HPLC and mass spectroscopy.
NMR spectroscopy of the interaction of RANTES and Heparin disaccharides -NMR
experiments were recorded at 30°C on a Bruker DRX600 spectrometer equipped with triple axis gradients using a 5 mm triple inverse resonance probehead. Heparin disaccharides I-A, II-A and II-S were added to a solution containing 300 µM 15 N labeled RANTES at pH 3.2 in a 0.6:1 ratio. Wheatgerm SPA beads (Amersham) were solubilized in PBS to 50 mg/ml, and diluted in the binding buffer to 10 mg/ml, and the final concentration in the assay was 0.25 mg/well.
Membranes expressing CCR1 or CCR5 were stored at -80ºC and diluted in the binding buffer to 80 µg/ml. Equal volumes of membrane and bead stocks were mixed before performing the assay to reduce background. The final membrane concentration was 2 µg/ml and that of [ 125 I]-RANTES was 0.1nM. The plates were incubated at room temperature with agitation for 4 hours. Radioactivity was measured and data analyzed as described above for the heparin binding assay.
Chemotaxis assays  The proteins were analyzed for their ability to induce the directional migration of freshly isolated monocytes purified from buffy coats and RBL/CCR5 transfectants (23) using the modified micro-Boyden chamber as previously described (24) .
For monocyte chemotaxis, 3 µm pore size filters were used, and the chambers incubated 30 min at 37 o C, whereas for the RBL/CCR5 assays, filters with 12 µm pores were used. and the incubation time was 45 min. 
HIV-1 infection enhancement assay -

RESULTS
Purification and characterization of the RANTES mutants  The enzymic digestion using
Endoproteinase Arg C of the MKKKWPR-RANTES mutant constructs yielded proteins which had the expected sequence as ascertained by mass spectroscopy ( Table 1) . The proteins were all >90% pure as estimated by reverse-phase HPLC with the exception of the R47A mutant which was 80% pure. (Fig 2) .
Heparin disaccharide/RANTES interaction as measured by NMR
Heparin affinity and Mono S chromatographies  RANTES elutes at 0.8 M NaCl on heparin affinity chromatography. Since the mutations carried out remove a basic residue, presumed to play a role in heparin binding, a decrease of the concentration of NaCl required to elute all the mutants was observed for the mutations with the exception of K56A (Table 2) .
Similarly, as can be predicted on the removal of basic residues, a decrease in NaCl concentration was required to elute the proteins from the Mono S column, again with two exceptions, K45A and K56A. The difference in NaCl concentration required for elution from the Mono S column and that required for the elution from the Heparin column was determined for all mutants. Only the mutants in the 40s region showed a positive value, indicating that these residues may play a role in the specific interaction with heparin. (15) Equilibrium competition assays  The integrity of the recombinant proteins was verified using receptor binding assays on two RANTES receptors, CCR1 and CCR5 ]-RANTES showed a 30-100-fold loss of affinity for CCR1, with a mean IC 50 of 380 + 147 nM (n=5) (Fig 3A) .
In vitro chemotaxis assays  The ability of the mutants to activate RANTES receptors was assessed by their ability to induce monocyte chemotaxis, mediated through CCR1, and chemotaxis of RBL/CCR5 transfectants. Again, as observed in the receptor binding studies, the single mutations did not significantly alter the ability of the protein to induce monocyte chemotaxis (results not shown), and the triple 50s mutant had an EC 50 value comparable to the WT protein, although a reduction in efficacy was observed (Fig 4A) . In accordance with its decreased affinity for CCR1, the triple 40's mutant had a significantly reduced ability to recruit monocytes, only showing full efficacy at 1 µM (Fig 4A) . The triple mutations were further analyzed and both were able to recruit T cells (results not shown) as well as RBL/CCR5 transfectants with EC 50 values comparable to the WT protein (Fig. 4B) (Fig 6A, Hoogewerf et al., 1997 ). This selectivity for the four GAG families is largely lost on mutation of the BBXB motif in the 40's loop ( Fig 6B) . As discussed above, the affinity for heparin is not changed, but there is now only a 24-fold difference between the affinity for heparin (IC 50 0.02 mg/ml) and chondroitin sulfate (IC 50 0.48 mg/ml). The affinities for heparan sulfate (IC 50 0.03 mg/ml) and dermatan sulfate (IC 50 0.21 mg/ml) for the triple mutant are also slightly higher compared to WT RANTES. In summary the triple 40's mutant loses the ability to discriminate between the four GAG families.
Inhibition of HIV-1 infectivity.
The triple 40's and 50's mutations were tested in their ability to inhibit the infection of PBMC's by the R5 strain, xx in comparison to RANTES. As is shown in Fig. 7 , the 50's cluster mutation retains full inhibitory properties, whilst the 40's cluster is still an efficient inhibitor in accordance with its receptor pharmacology, but shows a reduction in potency compared to the parent RANTES protein.
Enhancement of HIV-1 infectivity
The ability of the triple 40's mutant was compared with the WT protein and the non- (Fig. 1A and 1D ). The 40's loop is found to be the site of GAG interaction for the CC chemokines MIP-1α and MIP-1β (Fig. 1B and 1E) , whereas the C terminal helix is involved in IL-8 and MCP-1 GAG binding ( Fig. 1A and 1C ). Thus we decided to investigate two clusters of basic residues on RANTES since there was structural support in favor of both sites (Fig. 1F ).
The affinities of chemokines binding to heparin has been measured by a variety of techniques. Binding to heparin sepharose columns is often used. The MIP-1α R18A, R46A
and R48A mutants no longer bound to this column (36) and the MIP-1β R46A mutant could no longer bind when the chromatogrpahy was carried out in the presence of NaCl at physiological concentration (37) . However, IL-8 (15, SDF-1 (38) , and the mutants of RANTES that we have generated were all able to bind to a heparin sepharose column, but were eluted at a lower concentration of NaCl than the WT proteins. However, a comparison with cation exchange chromatographies indicated that only the mutants in the 40's region appeared to have specificity for heparin. The role of the 40's region was further supported by the shift of K45 and R47 observed on the binding of a disaccharide to 15N labelled RANTES, although the binding of the dissaccharide appeared to cause more perturbation than that observed for IL-8 (15) . The assay with iodinated ligands to immobilized heparin unambiguously identified that the 40's region has a major contribution to the capacity of RANTES to bind to this glycosaminoglycan moiety, whilst the cluster of basic residues in the 50's loop preceding the carboxy terminal helix plays no role in heparin binding.
It should be noted that the GAG binding sites are not restricted to the BBXB motif. It has been reported that cell surface GAG expression is not essential for the activity of chemokines in vitro, although they do serve a role in chemokine sequestration (39) .
Abrogation of the GAG binding sites either has no effect on receptor binding and activation in the case of IL-8, SDF-1 and MIP-1β, or has a profound effect as has been reported for MIP-1α binding to CCR1 (40) . We have seen both scenarios for RANTES: the mutation of the 44 RKNR 47 has no significant effect on its binding to and activation of CCR5, but profoundly affects its interaction with CCR1. This observation is supported by the lack of effect of CCR5 activation by the mutation of R46A in MIP-1β (37) whereas mutations in the same region of MIP-1α profoundly affect CCR1 binding, but have not been reported for CCR5. Inspection of the amino acid composition of the putative extracellular loops of these two receptors yields an indication why these differential effects are observed. CCR1 has 18 acidic Asp and Glu residues, but only 10 which contribute basic charge (7 Lys and Arg, and 6 His, which contributes 0.5 positive charge) whereas CCR5 has 7 acidic and 8 basic (7 Lys and Arg, and 2 His) residues. Thus it appears that the net electrostatic surface of CCR1 is likely to be negative, whereas in CCR5 it will be neutral. This indicates that perturbation of the there must be other residues that also contribute. One hypothesis can be drawn from inspection of the three dimensional structure, where His 23 is shown to be spatially close and could therefore play a role in this binding pocket. We are currently investigating this possibility. We have previously shown that RANTES exhibits a significant degree of selectivity for different GAG families (31) . Thus the selectivity previously described for the four GAG families by RANTES appears to be mediated to a major extent by the BBXB motif on the 40's loop. Effectively, RANTES mutants that are not able to oligomerize do not exhibit this enhancing effect (42) . Here we show that the 80% reduction of the ability of the RANTES protein to bind to heparin similarly prevents the protein from inducing enhanced viral infectivity.
However the ability of RANTES to inhibit HIV-1 infectivity depends on its ability to bind to CCR5, thereby preventing the virus from interacting with its co-receptor. The triple 40's mutant retains fully functional CCR5 binding activity, and is still able to inhibit HIV-1 infectivity of R5 HIV-1 strains.
This study has identified the principal heparin binding domain of RANTES, but has revealed several questions that need to be addressed. First, which are the residues or regions that are responsible for the residual heparin binding activity; second, the dissection of the individual residues in this pocket that play a predominant role in GAG binding and/or in CCR1 binding, and third, to address the question of whether increased viral infection is principally due to the fact that it facilitates interaction with the coreceptor though oligomerization, or whether the interaction of RANTES with GAGs induces cellular activation through a novel signal transduction mechanism. Lastly, we believe that such mutants will allow us to address the important question of the relevance of GAG binding to cellular recruitment in vivo, which has been hypothesized for many years without having been validated experimentally, and further investigates the role of GAG binding in controlling inflammation. The residues of RANTES mutated in this study. The images of chemokine monomers were produced using the program SwissPDBViewer (43) and the ray-tracing program POV-RAY.
Figure Legends
The RSCB entries of the structures were IL-8, 1il8; MIP-1α, 1b53; MCP-1, 1dok; SDF-1α, 1a15; Mip-1β, 1hum; RANTES, 1eqt. 
